YC W17 · Active

Indee Labs

Enabling T cell immunotherapy discovery, development and manufacturing

Class: Winter 2017
Status: Active
Industry: Healthcare
Location: San Francisco, CA, USA; Berkeley, CA, USA
Team size: 5

Website

http://www.indeelabs.com

About

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.